Stephen Hawking Responds to Movie Transcendence & Artificial Intelligence – Video

Posted on by


Stephen Hawking Responds to Movie Transcendence Artificial Intelligence
http://www.covertchronicle.com/stephen-hawking-responds-to-movie-transcendence-artificial-intelligence/ If the new artificial intelligence movie Transcendence didn #39;t scare the shit out of...

By: The Covert Chronicle

Go here to see the original:

Stephen Hawking Responds to Movie Transcendence & Artificial Intelligence - Video

Quasar Aerospace Industries, Inc. (QASP) Stock Chart Technical Analysis for 4/30/14 – Video

Posted on by


Quasar Aerospace Industries, Inc. (QASP) Stock Chart Technical Analysis for 4/30/14
Join My Private Trading Team - http://claytrader.com/join-the-trading-team/ Learn to Trade Without Emotion: http://claytrader.com/store/ Follow Me: @ClayTrader25 Like Me: https://www.facebook.com/c...

By: ClayTrader

View original post here:

Quasar Aerospace Industries, Inc. (QASP) Stock Chart Technical Analysis for 4/30/14 - Video

Johns Hopkins Joins the Food and Drug Administration's Centers of Excellence in Regulatory Science and Innovation …

Posted on by

Contact Information

Available for logged-in reporters only

Newswise The Johns Hopkins University is joining the Food and Drug Administrations Centers of Excellence in Regulatory Science and Innovation (CERSI), the Agencys academic partnership that promotes regulatory science. Faculty from the Johns Hopkins Krieger School of Arts and Sciences, the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins School of Medicine will lend their expertise to FDA staff and scientists, as well as participating CERSI faculty, in three FDA priority areas: clinical evaluations, social and behavioral science and food safety.

The FDA launched CERSI in 2011 to address scientific challenges in regulating the countrys food and drug and medical products at a time of rapid technological advancements. Johns Hopkins CERSI, thanks to its proximity to the FDA and to an extensive relationship with the Agency that includes the FDA Commissioners Fellows Program, will offer existing training, including certificates and degrees to FDA scientists and staff. Johns Hopkins will also develop curricular materials, including a new Master's in Food Science that will be offered beginning in the fall of 2015 through JHUs Krieger School, as well as online mini-symposia or courses in regulatory science offered across the University and Schools of Public Health and Medicine.

In addition to a strong foundation of collaboration with the Agency, our partnership with the FDA will leverage many other institutional strengths, said G. Caleb Alexander, MD, MS, associate professor of Epidemiology and Medicine and co-director of the Johns Hopkins Center for Drug Safety and Effectiveness. These include internationally renowned scholarship in regulatory science; innovative training through online platforms harnessing modern technologies; a nimble and organic operational approach; and the potential for self-sustaining programs that will continue to serve the FDAs strategic mission beyond this award.

To address the first strategic focus, improving clinical studies and evaluation, the Johns Hopkins CERSI will select specific projects for collaborative training and investigation with FDA scientists, drawing from expertise across a range of the Universitys centers, including the Center for Clinical Trials, the United States Cochrane Center, the Evidence-Based Practice Center and the Center for Drug Safety and Effectiveness.

The second strategic focus is strengthening social and behavioral science to support informed decisions. Here, Johns Hopkins will leverage several centers whose work touches upon social and behavioral aspects of healthcare delivery and regulation, including the Institute for Tobacco Control and the Center for Communications Programs. This is important, since the best science in the world does little good if the results of such investigations cannot be communicated to the end user, the general public, who the FDA serves, said Dr. Alexander.

The final strategic focus is the development of a new prevention-focused food safety system. Johns Hopkins has a wealth of scientists that are working on highly relevant areas of food safety. The Center for a Livable Future, housed at the Johns Hopkins Bloomberg School of Public Health, promotes research to develop and communicate information about the complex interrelationships among diet, food production, environment and human health, to advance an ecological perspective in reducing threats to the health of the public and to promote policies that protect health, the global environment and the ability to sustain life for future generations.

These partnerships enrich the breadth and depth of FDA expertise, enabling us to base our regulatory decisions on the most current scientific evidence, said Stephen Ostroff, MD, the FDAs Acting Chief Scientist. They also enable FDA to bring its expansive experience to academia, ensuring that the new scientific approaches being developed at these institutions can be applied in a way that increases their usefulness for evaluating FDA-regulated products. Most importantly, patients and consumers will ultimately benefit from the investment."

# # #

Read the original:
Johns Hopkins Joins the Food and Drug Administration's Centers of Excellence in Regulatory Science and Innovation ...

Hardik Soni, M.D., Combines Anti-aging Sculptra Aesthetic and Ultherapy to Lift, Tighten and Restore Youthful Volume …

Posted on by

Summit, NJ (PRWEB) May 05, 2014

Hardik Soni, M.D., Medical Director of Ethos Spa, Skin and Laser Centers in Summit and Englewood, New Jersey, is now offering the effective and long-lasting combination of Sculptra Aesthetic and Ultherapy as a non-surgical facelift alternative that takes years of the patients appearance.

Sculptra Aesthetic is volume-restoring filler made of poly-l-lactic acid that stimulates new collagen production to replace the natural volume (fat) loss that occurs in the facial area during the aging process. Sculptra injections take only 15-20 minutes and provide natural-looking results that can last up to two years. Ultherapy, an intensive ultrasound treatment that takes an additional 30-90 minutes, works to lift and tighten loose or saggy skin on the brow, jawline, chin and neck. Ultherapy also works to stimulate collagen production in the deep tissue layers of the face.

For anyone looking for an alternative to the surgical face-lift, the Sculptra Aesthetic and Ultherapy treatments could be the answer. Each works individually to produce skin-tightening and volumizing effects and multi-layer tissue stimulation that results in the full, firm facial features of youth.

Individually, each treatment provides the patient with its own unique anti-aging benefits, but when used together, the results can be dramatic. A good candidate for combining Ultherapy and Sculptra Aesthetic treatments is someone who is experiencing mild skin drooping and volume loss. Although the results are not permanent, they are long lasting. Patients can go two to three years between touch-ups to their Sculptra Aesthetic treatments, and Ultherapy treatments can be repeated for additional tightening with no additional risks involved.

The Sculptra and Ultherapy combination requires minimum downtime, leaves no scars, and is relatively pain-free. Patients realize a significant difference in their appearance after the first treatment, but the anti-aging characteristics of the Sculptra.

Aesthetic/Ultherapy combination treatment reveal themselves over time in a gradual and natural process.

For more information on Sculptra Aesthetic, Ultherapy, and other non-surgical facelift alternatives available at the Ethos Spa, Skin and Laser Center, visit the Ethos Spa website, call the Summit location at (908) 273-5400, or call the Englewood location at (201) 541-6600.

About Hardik Soni, M.D. and Ethos Spa, Skin and Laser Center:

Ethos Spa, Skin and Laser Center Medical Director Hardik Soni, M.D. strives to achieve the best possible results for his patients by drawing on his experience and proficiency with multiple laser platforms, earned from having performed more than 15,000 cosmetic treatments including botulinum injection (Botox and Dysport), dermal fillers (Juvederm, Restylane, Radiesse), laser hair removal, chemical peels and laser skin rejuvenation. He is a platinum level injector with Allergan, the makers of Botox and Juvederm; his primary focus is on minimally invasive and non-invasive cosmetic procedures including Aesthera Candela, Cutera, Fraxel, Sciton and Syneron. Soni believes in a more conservative approach to cosmetic procedures, and prioritizes patient education. Clients are able to decide on their own ideal treatment after discussing their options, and weighing the expected outcomes, costs and risks.

Original post:
Hardik Soni, M.D., Combines Anti-aging Sculptra Aesthetic and Ultherapy to Lift, Tighten and Restore Youthful Volume ...

Young blood reverses brain aging

Posted on by

Young blood really does rejuvenate the brain, at least in mice, raising hopes that molecules in the blood may be identified to do the same for humans, according to a study stemming from the ongoing research of a young UC San Francisco scientist, Saul Villeda, Ph.D.

The research, on which Villeda collaborated with scientists at Stanford University, identified anatomical, molecular and biochemical evidence of cognitive improvements and other forms of rejuvenation in old mice when they were connected to the circulatory system of young ones. Results were published online in Nature Medicine on May 4.

Anatomically, it was clear that these mice formed more structural and functional connections between neurons, or nerve cells, while they also turned on more genes associated with the formation of new nerve connections.

Saul Villeda

Furthermore, the researchers found that a protein called Creb became more activated in the brain region known as the hippocampus, and that this increased activity was associated with the anatomical and cognitive improvements the team observed.

We know that something in the young blood leads to Creb activation, and the Creb is a master regulator of gene activity in the brain that is associated with the formation of new connections between neurons underlying learning and memory, Villeda said, adding that Creb activation is known to decrease in both normal human aging and in Alzheimers disease.

In the behavioral experiments, old mice were injected with either old or young blood. Cognitively, old mice with young blood coursing through their veins performed better. When immersed in water, they were better able to recall the location of a submerged platform and climb onto it. In a separate, fear-conditioning exercise, they responded more quickly to stimuli normally perceived as threatening, a behavior important for survival.

Identifying and getting rid of aging factors in old blood, or supplying youthful factors from young blood, might both be worthwhile strategies to combat aging, Villeda says. But dont try injecting yourself with saved samples of your young blood at home just yet.

I definitely think this is something that could translate to humans, but we still lack some key pieces of knowledge, Villeda said. We dont know what might be the appropriate regimen or dosage. Most importantly, while young blood seems to improve muscle, liver, heart and brain, we havent extensively studied potentially detrimental long-term effects.

Villeda, now an assistant professor of anatomy at UCSF, began the experiments as a Stanford graduate student and then as a postdoctoral fellow working in the lab of Tony Wyss-Coray, Ph.D., professor of neurology in the Stanford University School of Medicine and the senior scientist for the Nature Medicine study.

See more here:
Young blood reverses brain aging

NATO must invest in defense to counter Russia: US

Posted on by

Russia is trying to test NATO's mettle and members of the transatlantic alliance must bolster military spending in the face of Moscow's challenge, US Defense Secretary Chuck Hagel warned Friday.

The 28 members of NATO have responded to Russia's intervention in Ukraine with "resolve," Hagel said, "but over the long term, we should expect Russia to test our alliance's purpose, stamina and commitment."

Russia's annexation of Crimea and its backing of separatists in eastern Ukraine "has reminded NATO of its founding purpose," he said.

After the Cold War, the alliance had looked to forge a partnership with its old adversary.

But after Moscow's moves in Ukraine, "NATO must stand ready to revisit the basic principles underlying its relationship with Russia," he said.

Hagel's press secretary, Rear Admiral John Kirby, declined to describe Russia as an "enemy" of the United States.

NATO's deputy secretary general, US diplomat Alexander Vershbow, however said Thursday that Moscow had be to seen as "more of an adversary than a partner."

- Crucial choice -

In his speech, Hagel told an audience at the Wilson Center think tank in Washington that the alliance faced a crucial choice in light of Russia's assertive stance in Ukraine -- to stand firm or to retreat.

"Future generations will note whether... at this moment of challenge, we summoned the will to invest in our alliance," he warned.

Continue reading here:

NATO must invest in defense to counter Russia: US